銆€銆€鎹潯渚嬶紝閫熶腹鐨勬椿鎬х墿璐ㄤ负姘㈡捍閰稿父灞遍叜銆傜粡杩囪瘎浼帮紝涓撳灏忕粍鏃犳硶灏辫娣诲姞鍓傚娑堣垂鑰呭拰鐜鐨勫畨鍏ㄦ€у緱鍑虹粨璁猴紝涔熸棤娉曞氨娣诲姞鍓傚湪鑲茶偉楦″拰鐏浮涓殑鍔熸晥寰楀嚭缁撹銆�
銆€銆€閮ㄥ垎鍘熸枃鎶ラ亾濡備笅锛�
銆€銆€Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the coccidiostat STENOROL® containing halofuginone hydrobromide (halofuginone HBr) as active substance. The FEEDAP Panel was not able to conclude on the safety of STENOROL®for chickens and turkeys for fattening at the highest proposed use level. No incompatibilities or interactions with feedingstuffs, carriers, other approved additives or medicinal drugs are expected. Halofuginone HBr does not have antimicrobial activity at the highest dose proposed; it is not expected to exert adverse effects on chicken gut microbiota or selec for resistance and cross鈥恟esistance with other antimicrobials. The Panel cannot conclude on the genotoxic potential of halofuginone HBr since an appropriate in vivo follow鈥恥p to exclude the mutagenic effect of the compound was not available. Therefore, the FEEDAP Panel cannot conclude on the safety of halofuginone HBr for the consumer. The additive is toxic by inhalation, dermal and ocular routes and is very irritant to both the eye and the skin. It is considered also a skin sensitiser. Inhalation exposure is considered a risk to persons handling the additive. Since the lack of genotoxic potential of halofuginone HBr has not been adequately demonstrated, it should be considered as an additional potential concern to users handling the additive. Due to limitations in some of the ecotoxicological studies, no conclusions can be drawn on the safety of the additive for the environment. The FEEDAP Panel is not in the position to conclude on the efficacy of STENOROL® in chickens for fattening and in turkeys for fattening.
銆€銆€鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屼緵缃戝弸鍙傝€冿紝娆㈣繋杞浇锛岃浆杞借娉ㄦ槑鍑哄锛佹湁浠讳綍鐤戦棶锛岃鑱旂郴news@www.sqrdapp.com銆�